Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,080 | 59 | 92.6% |
| Education | $86.91 | 2 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $210.58 | 9 | $0 (2019) |
| Janssen Biotech, Inc. | $173.75 | 8 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $113.34 | 1 | $0 (2022) |
| Celgene Corporation | $113.06 | 6 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $93.95 | 7 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $77.67 | 5 | $0 (2017) |
| Amgen Inc. | $68.01 | 5 | $0 (2018) |
| Genentech USA, Inc. | $65.28 | 5 | $0 (2019) |
| PFIZER INC. | $52.59 | 4 | $0 (2018) |
| Lilly USA, LLC | $48.38 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $113.34 | 1 | AstraZeneca Pharmaceuticals LP ($113.34) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $233.18 | 14 | E.R. Squibb & Sons, L.L.C. ($46.74) |
| 2018 | $365.40 | 15 | Janssen Biotech, Inc. ($118.49) |
| 2017 | $442.80 | 30 | Novartis Pharmaceuticals Corporation ($77.67) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/20/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $113.34 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 12/30/2019 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Oncology | ||||||
| 10/31/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug), Aliqopa | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Oncology | ||||||
| 10/03/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: Oncology | ||||||
| 09/12/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Oncology | ||||||
| 08/22/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Oncology | ||||||
| 07/11/2019 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: BioOncology | ||||||
| 06/27/2019 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Oncology | ||||||
| 06/20/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.69 | General |
| Category: Oncology | ||||||
| 05/30/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), Erleada | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Oncology | ||||||
| 03/09/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $44.12 | General |
| Category: Oncology | ||||||
| 01/10/2019 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Oncology | ||||||
| 11/12/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.98 | General |
| Category: Oncology | ||||||
| 09/11/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), Erleada | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Oncology | ||||||
| 05/29/2018 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Food and Beverage | Cash or cash equivalent | $12.01 | General |
| Category: Oncology | ||||||
| 05/22/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Oncology | ||||||
| 05/11/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA, DARZALEX | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Oncology | ||||||
| 05/08/2018 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Oncology | ||||||
| 04/18/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Oncology | ||||||
| 04/17/2018 | Janssen Biotech, Inc. | DARZALEX (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Oncology | ||||||
| 04/10/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 115 | 263 | $38,075 | $19,493 |
| 2020 | 4 | 137 | 283 | $35,762 | $15,348 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 170 | $20,400 | $10,552 | 51.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 79 | $13,825 | $7,451 | 53.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $3,850 | $1,490 | 38.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 211 | $25,320 | $11,164 | 44.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 26 | 26 | $5,070 | $1,732 | 34.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 20 | $3,500 | $1,636 | 46.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 23 | 26 | $1,872 | $816.92 | 43.6% |
About Dr. Kenneth Pennington, M.D
Dr. Kenneth Pennington, M.D is a Specialist healthcare provider based in Goshen, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144200684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Pennington, M.D has received a total of $1,167 in payments from pharmaceutical and medical device companies, with $113.34 received in 2022. These payments were reported across 61 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,080).
As a Medicare-enrolled provider, Pennington has provided services to 252 Medicare beneficiaries, totaling 546 services with total Medicare billing of $34,841. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Medical Oncology
- Location Goshen, IN
- Active Since 01/19/2006
- Last Updated 03/11/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1144200684
Products in Payments
- KEYTRUDA (Biological) $170.87
- CALQUENCE (Drug) $113.34
- IMBRUVICA (Drug) $74.99
- OPDIVO (Biological) $69.17
- Abraxane (Drug) $68.91
- Imbruvica (Drug) $44.12
- IBRANCE (Drug) $42.25
- Kyprolis (Biological) $40.67
- CYRAMZA (Drug) $33.38
- AFINITOR (Drug) $31.35
- Erleada (Drug) $29.53
- ZYTIGA (Drug) $29.09
- Neulasta (Biological) $27.34
- TECENTRIQ (Biological) $25.70
- DARZALEX (Biological) $25.54
- JADENU (Drug) $24.88
- SPRYCEL (Drug) $24.78
- Revlimid (Drug) $22.12
- Pomalyst (Drug) $22.03
- TASIGNA (Drug) $21.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Goshen
Mark Ranzinger, Md, MD
Specialist — Payments: $16,297
Min Yan, M.d, M.D
Specialist — Payments: $363.53
Dr. Greg Mielke, M.d, M.D
Specialist — Payments: $76.72
Joan Szynal, M.d, M.D
Specialist — Payments: $69.74
Dr. Laura Morris, M.d, M.D
Specialist — Payments: $43.07
Maria Garcia, M.d, M.D
Specialist — Payments: $24.37